As part of our semaglutide program, JY MedTech has successfully completed the registration of the semaglutide active pharmaceutical ingredient (API) Korean Drug Master File (K-DMF) in South Korea. The API registration certificate has been issued by the Korean Ministry...
JYMed Peptide has been independently assessed by EcoVadis Bronze Medal Dec 2025, a globally recognized sustainability ratings provider used across supply chains. In the December 2025 assessment, JYMed Peptide achieved an overall score of 70/100, placing us in the 83rd...
Innovation at the Core of Peptide Manufacturing Advanced peptide synthesis technologies are essential to meeting the growing demand for complex peptides in metabolic, oncological, and cosmetic therapeutics. Achieving reliable and scalable production requires mastery...
How JYMed Delivers Integrated, cGMP-Compliant Peptide CDMO Solutions from Discovery to Delivery Introduction: The Critical Role of Peptides in Modern Therapeutics Peptides are reshaping the pharmaceutical landscape, driving innovation across metabolic therapies,...
中文